Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2005
11/30/2005EP1178740B1 Sports drink comprising micronutrients and viable lactobacilli
11/30/2005EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP1071474B1 Substituted porphyrins
11/30/2005EP0932403B1 Condensed (hetaryl-substituted) 1-benzyl-3-pyrazol derivates for treating diseases of the cardiovascular and central nervous systems
11/30/2005EP0925291B1 Spirocyclic dopamine receptor subtype ligands
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005CN1703425A Crystallization of IGF-1
11/30/2005CN1703416A Methods and compositions comprising nitric oxide donors and opioid analgesics
11/30/2005CN1703410A Isoquinoline compounds and medicinal use thereof
11/30/2005CN1703407A Inhibitors of fatty acid amide hydrolase
11/30/2005CN1703405A Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/30/2005CN1703404A Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz [b,f]azepine-5-carboxamide and new crystal forms thereof
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703222A Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of dementia and Parkinsons
11/30/2005CN1703214A Amino acid compositions for improving central functions
11/30/2005CN1703213A Alpha 2b 0r 2b/2c adrenoceptor agonists for the treatment of neurodegeneration
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1229388C N-terminal modified protein compositions and methods therefor
11/30/2005CN1229381C Macrolides compound
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229373C Piperidinee derivatives as neurokinin1 antagonists
11/30/2005CN1229371C Benzopyranyl guanidine derivtives, process for preparation thereof and pharmaceutical compositions containing them
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229349C Pyridine-3-carboxylic acid derivative
11/30/2005CN1229345C N-(indolcarbonyl) piperazin derivatives
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229335C Nervinolin derivatives
11/30/2005CN1229331C Inhibitor of monoamine uptake
11/30/2005CN1229324C Extraction process of tanshin general phenolic acid and its prepn and use
11/30/2005CN1229137C New therapeutic uses of SMR1 peptides
11/30/2005CN1229130C Medicine for treating kidney and spleen and preparing method thereof
11/30/2005CA2502142A1 Transdermal therapeutic systems
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969724 Compounds
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes
11/29/2005US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders
11/29/2005US6969717 Azaindole kinase inhibitors
11/29/2005US6969712 Alzheimer's disease; central nervous system disorders; antidepressants; antidiabetic agents; analgesics
11/29/2005US6969709 Macrocycles useful in the treatment of Alzheimer's disease
11/29/2005US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage
11/29/2005US6969516 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
11/29/2005CA2344108C Novel derivatives of cyclobuta-indole carboxamide, process for preparing them and pharmaceutical compositions containing them
11/29/2005CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
11/24/2005WO2005110490A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception
11/24/2005WO2005110412A1 Neuroprotective properties of dextrorotatory morphinans
11/24/2005WO2005110403A1 The non-opiate heroin withdrawal medicines
11/24/2005WO2005110393A1 Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease
11/24/2005WO2005034971A3 Antiviral agent
11/24/2005WO2005000205A3 Methods and compositions for modulating serum cortisol levels
11/24/2005WO2004091630A8 Remedies for diseases to be applied to eye
11/24/2005WO2004089313A3 Novel olanzapine forms and related methods of treatment
11/24/2005US20050261502 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
11/24/2005US20050261495 Lactam Compound
11/24/2005US20050261372 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator
11/24/2005US20050261371 Administering valproic acid or salts to treat Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, stroke, and other nervous system disorders
11/24/2005US20050261358 Cyclohexylurea compounds
11/24/2005US20050261357 Brain dysfunction or neuropathy caused by loss or degeneration of the neuron; differentiation of a stem cell; 14-(5-methoxy-1H-indole-2-yl)-tetradecane-1-ol
11/24/2005US20050261345 beta-amyloid antiaggregating properties; 2,5-Bis-{6-[ethyl-(2-methoxy-benzyl)-amino]-hexylamino}-[1,4]benzoquinone for example
11/24/2005US20050261343 Anthranilamides and their use as pharmaceutical agents
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261323 Medical uses of novel carbamate-substituted pyrazolopyridine derivatives
11/24/2005US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta
11/24/2005US20050261306 Anti-neurodegenerative agents
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261304 1,3-benzothiazol-2-yl[2-({4-[(4-methylpiperazin-1-yl)methyl]benzyl}oxy)pyrimidin-4-yl]acetonitrile; crosses the Blood brain barrier
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261285 Tetrahydropyran derivatives and their use as therapeutic agents
11/24/2005US20050261284 Diazinopyrimidines
11/24/2005US20050261282 Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines
11/24/2005US20050261281 Pharmaceutical compounds
11/24/2005US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia
11/24/2005US20050261276 Novel sulphones for inhibition of gamma secretase
11/24/2005US20050261274 1-[3-Methyl-1-(5-methyl-6-oxo-benzo[b]-1,4-diazepin-7-ylcarbamoyl)-butyl]-cyclohexanecarboxylic acid amide; inhibit processing of amyloid precursor protein (production of A beta -peptide); neurological disorders related to beta -amyloid production: Alzheimer's disease, Down's Syndrome
11/24/2005US20050261271 Dipeptidyl peptidase inhibitors
11/24/2005US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
11/24/2005US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives
11/24/2005US20050261209 Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/24/2005US20050261198 sulfur-containing proanthocyanidin oligomer having a low molecular weight, made by reacting a precursor with a mercapto compound has improved bioavailability; antioxidant; derived from buckwheat
11/24/2005US20050261194 Use of thymulin-like peptides for making pain-relieving medicines
11/24/2005US20050261192 Novel polypeptide and its DNA
11/24/2005US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy
11/24/2005US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/24/2005US20050261182 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/24/2005US20050261167 Compositions for sleeping disorders
11/24/2005US20050261163 Pharmaceutical products, preparation and uses thereof
11/24/2005US20050260767 Treatment with cytokines
11/24/2005US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom
11/24/2005US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators
11/24/2005US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon
11/24/2005US20050260601 Recombinant mutants of rhabdovirus and methods of use thereof
11/24/2005US20050260577 Detection of neurodegenerative disorders
1 ... 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 ... 1833